KYSENSE® is a CE-marked class III medical device, a crosslinked hyaluronic acid dermal filler for the facial anatomy, manufactured by Swiss based KYLANE LABORATOIRES, an innovative biomedical company dedicated to breakthrough research and clinical science, with a team of experts bringing 50 years of experience in HA science and technologies, contributing to more than 20 patents globally.
Claire Williams, chief executive of CIRCA SKIN with an existing successful aesthetic portfolio, is delighted to be appointed as the exclusive global distributor for KYSENSE®, which launched in February 2021.
Claire says, “KYSENSE® represents an exciting innovation and step forward in what clinical practitioners can offer their patients and we are thrilled to be launching this advancement in HA technology.
“In addition, we are revolutionising the business aspect for our customers, with the launch of an educational digital platform and subscription service to support our clinicians in maximising their clinical and commercial returns”.
KYSENSE® has been developed by scientists in collaboration with doctors with decades of experience in the HA dermal filler market, and who contribute to peerreviewed publications in HA technology and facial aesthetics.
The KYSENSE® manufacturing process (HA Protect) preserves the long HA chains leading to a smooth, supple gel matrix with advantageous rheological properties, without the addition of lidocaine.
KYSENSE® offers versatility for the injector, with four product choices to treat most areas of the face, offering increased injection precision with a higher projection capability while respecting the four key rheological parameters. For the patient, KYSENSE® offers a natural look and feel with high patient satisfaction.
KYSENSE®: redefining the science and aesthetic of facial anatomy.
The four lines in the product range are outlined below.
For more information visit circaskin.co.uk